Adult Solid Tumor

26 registered clinical trials studyying Adult Solid Tumor — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Me NCT07246863	CatalYm GmbH	Phase 2
Recruiting	Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Met NCT07098988	CatalYm GmbH	Phase 2
Not Yet Recruiting	A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor NCT06277804	Letolab	Phase 1
Active Not Recruiting	A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Adva NCT06403436	TOLREMO therapeutics AG	Phase 1
Active Not Recruiting	Neoadjuvant Immunotherapy Combined With the Anti-GDF-15 Antibody Visugromab to Treat Muscle Invasive Bladder C NCT06059547	CatalYm GmbH	Phase 2
Recruiting	Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumou NCT05752552	DeuterOncology	Phase 1
Unknown	Study of LTC004 in Subjects With Advanced Malignant Tumors NCT05666635	Letolab	Phase 1
Completed	Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 NCT05400265	Shanghai Henlius Biotech	Phase 1
Terminated	Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors NCT05357898	SQZ Biotechnologies	Phase 1 / Phase 2
Terminated	Study of RP-6306 With Gemcitabine in Advanced Solid Tumors NCT05147272	Debiopharm International SA	Phase 1
Terminated	Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors NCT04892043	SQZ Biotechnologies	Phase 1
Completed	Combining Epigenetic And Immune Therapy to Beat Cancer. NCT04705818	Institut Bergonié	Phase 2
Completed	Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy NCT04538625	Napo Pharmaceuticals, Inc.	Phase 3
Completed	Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors NCT04084951	SQZ Biotechnologies	Phase 1
Completed	Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling NCT03760952	Immatics US, Inc.	—
Completed	Hydrogen Gas for Cancer Rehabilitation NCT03818347	Fuda Cancer Hospital, Guangzhou	N/A
Completed	Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and You NCT03445858	Children's Hospital Medical Center, Cincinnati	EARLY_Phase 1
Completed	Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence NCT03303365	Juergen Debus	N/A
Suspended	CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2 NCT03253575	Mitra RxDx, Inc.	—
Terminated	Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors NCT03061305	Strata Oncology	—
Active Not Recruiting	Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (T NCT02568267	Hoffmann-La Roche	Phase 2
Completed	A Phase I Trial of AZD3965 in Patients With Advanced Cancer NCT01791595	Cancer Research UK	Phase 1
Completed	A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative P NCT01269918	The Cleveland Clinic	N/A
Completed	Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Ind NCT01332721	Tracon Pharmaceuticals Inc.	Phase 1
Completed	Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer NCT01037790	Abramson Cancer Center at Penn Medicine	Phase 2
Withdrawn	Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery NCT00041171	Alliance for Clinical Trials in Oncology	Phase 3